صفحه اصلی >  آموزش  

آموزش

روابط عمومی انجمن آترواسکلروز ایران :
ESC Congress 2018 | Day 4 Highlights
Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss partial oral treatment of left-sided infectious endocarditis (POET); early vs. deferred invasive ACS examination and treatment (VERDICT); pre-treatment with P2Y12 receptor antagonists not associated with improved UA/NSTEMI clinical outcomes (SCAAR); and a mendelian randomized study examining effects of triglyceride-rich lipoproteins on CV risk - American College of Cardiology

 ٠٩:٢٩ - سه شنبه ٢٠ آذر ١٣٩٧ - تعداد نظرات : ٠ادامه خبر >>

روابط عمومی انجمن آترواسکلروز ایران :
ESC Congress 2018 | Day 3 Highlights
Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss ticagrelor and aspirin vs. DAPT followed by aspirin monotherapy (GLOBAL LEADERS); rivaroxaban vs. placebo in HF patients (COMMANDER HF); PAD in critical limb ischemia; tafamidis in transthyretin amyloid cardiomyopathy (ATTR-ACT); percutaneous MV repair in secondary mitral regurgitation and reduced LVEF (MITRA-FR); and a simple risk model to predict CVD or MI in stable CAD (CLARIFY Registry)-American College of Cardiology.

 ٠٩:٠٧ - سه شنبه ٢٠ آذر ١٣٩٧ - تعداد نظرات : ٠ادامه خبر >>

روابط عمومی انجمن آترواسکلروز ایران :
ESC Congress 2018 | Day 2 Highlights
Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss aspirin for primary CV prevention in diabetics (ASCEND Aspirin); aspirin to reduce risk of initial vascular events (ARRIVE); medically ill patient assessment of rivaroxaban for reducing post-discharge venous thromboembolism (MARINER); omega-3 fatty acids for primary CV prevention in diabetics (ASCEND Omega-3); restrictive vs. liberal red blood cell transfusion in cardiac surgery (TRICS III)-American College of Cardiology

 ٠٨:٥٣ - سه شنبه ٢٠ آذر ١٣٩٧ - تعداد نظرات : ٠ادامه خبر >>

روابط عمومی انجمن آترواسکلروز ایران :
ESC Congress 2018 | Day 1 Highlights
Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss aspirin for primary CV prevention in diabetics (ASCEND Aspirin); aspirin to reduce risk of initial vascular events (ARRIVE); medically ill patient assessment of rivaroxaban for reducing post-discharge venous thromboembolism (MARINER); omega-3 fatty acids for primary CV prevention in diabetics (ASCEND Omega-3); restrictive vs. liberal red blood cell transfusion in cardiac surgery (TRICS III)

 ١٥:٥٠ - دوشنبه ١٩ آذر ١٣٩٧ - تعداد نظرات : ٠ادامه خبر >>

روابط عمومی انجمن آترواسکلروز ایران :
مراسم افتتاحیه بیستمین کنگره بین المللی تازه های قلب و عروق
مراسم افتتاحیه بیستمین کنگره بین المللی تازه های قلب و عروق -پارت اول

 ١٣:١٨ - چهارشنبه ١٤ آذر ١٣٩٧ - تعداد نظرات : ٠ادامه خبر >>

2 3 4 5 6 7 8 9 10 صفحه بعدی >>

جستجو

+